OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 114 ( 10 ) ISSN 0027-8424
暂无分享,去创建一个
R. König | M. Emerman | G. Lenzi | Baek Kim | O. Fackler | Xiaoyu Pan | Libin Abraham | O. Keppler | E. Lim | O. Fregoso | F. Rutsch | Ina Ambiel | S. Schwarz | H. Baldauf | Margarethe Martin | M. Trotard | L. Nguyen | M. Burggraf | Lena Stegmann | Helena Lejk | Hanna-Mari Baldaufa | Lena Stegmanna | Sarah-Marie Schwarza | Ina Ambiela | Maud Trotardd | Margarethe Martina | Manja Burggrafe | Gina M. Lenzif | Helena Lejkb | Xiaoyu Pand | Oliver I. Fregosog | Efrem S. Limg | Libin Abrahamd | Laura A. Nguyenf | Frank Rutschh | Renate Könige | Baek Kimf | Michael Emermang | Oliver T. Facklerd | Oliver T. Kepplera
[1] T. Hope,et al. HIV-1 capsid: the multifaceted key player in HIV-1 infection , 2015, Nature Reviews Microbiology.
[2] Jinming Zhou,et al. Characterization of the interactions between SIVrcm Vpx and red-capped mangabey SAMHD1. , 2015, The Biochemical journal.
[3] I. Taylor,et al. Molecular Determinants for Recognition of Divergent SAMHD1 Proteins by the Lentiviral Accessory Protein Vpx , 2015, Cell host & microbe.
[4] F. Lasitschka,et al. SAMHD1's protein expression profile in humans , 2015, Journal of leukocyte biology.
[5] C. Aiken,et al. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. , 2014, Virology.
[6] M. Malim,et al. New insights into an X-traordinary viral protein , 2014, Front. Microbiol..
[7] I. Taylor,et al. Structural basis of lentiviral subversion of a cellular protein degradation pathway , 2013, Nature.
[8] J. Luban,et al. Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration , 2014, Retrovirology.
[9] O. Fackler. Restrictions to HIV-1 replication in resting CD4+ T lymphocytes , 2013, Retrovirology.
[10] Michael Emerman,et al. Evolutionary Toggling of Vpx/Vpr Specificity Results in Divergent Recognition of the Restriction Factor SAMHD1 , 2013, PLoS pathogens.
[11] Hanna-Mari Baldauf,et al. Restrictions to HIV-1 replication in resting CD4+ T lymphocytes , 2013, Cell Research.
[12] M. Benkirane,et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.
[13] Baek Kim,et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. , 2013, Cell host & microbe.
[14] R. König,et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells , 2012, Nature Medicine.
[15] Y. Crow,et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells , 2012, Retrovirology.
[16] O. Schwartz,et al. Restricting HIV the SAMHD1 way: through nucleotide starvation , 2012, Nature Reviews Microbiology.
[17] Baek Kim,et al. Tight Interplay among SAMHD1 Protein Level, Cellular dNTP Levels, and HIV-1 Proviral DNA Synthesis Kinetics in Human Primary Monocyte-derived Macrophages* , 2012, The Journal of Biological Chemistry.
[18] Michael Emerman,et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. , 2012, Cell host & microbe.
[19] Baek Kim,et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.
[20] R. König,et al. SAMHD1-Deficient CD14+ Cells from Individuals with Aicardi-Goutières Syndrome Are Highly Susceptible to HIV-1 Infection , 2011, PLoS pathogens.
[21] Geoff Kelly,et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.
[22] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[23] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[24] J. Luban,et al. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon , 2011, Retrovirology.
[25] N. Bhardwaj,et al. Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells , 2011, Journal of Virology.
[26] T. Gramberg,et al. Evidence for an Activation Domain at the Amino Terminus of Simian Immunodeficiency Virus Vpx , 2009, Journal of Virology.
[27] Rajnish Kaushik,et al. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. , 2009, Cell host & microbe.
[28] A. Bergamaschi,et al. The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection , 2009, Journal of Virology.
[29] M. Mcclure,et al. A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. , 2009, Journal of virological methods.
[30] J. Luban,et al. Characterization of Simian Immunodeficiency Virus SIVSM/Human Immunodeficiency Virus Type 2 Vpx Function in Human Myeloid Cells , 2008, Journal of Virology.
[31] M. Otsuka,et al. Vpx Is Critical for Reverse Transcription of the Human Immunodeficiency Virus Type 2 Genome in Macrophages , 2008, Journal of Virology.
[32] Smita Srivastava,et al. Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection , 2008, PLoS pathogens.
[33] C. June,et al. Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells , 2007, Journal of Virology.
[34] O. Keppler,et al. HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription , 2007, Proceedings of the National Academy of Sciences.
[35] J. Darlix,et al. Retrovirology BioMed Central , 2006 .
[36] W. Greene,et al. Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef , 2005, Journal of Virology.
[37] R. Bambara,et al. Macrophage Tropism of HIV-1 Depends on Efficient Cellular dNTP Utilization by Reverse Transcriptase* , 2004, Journal of Biological Chemistry.
[38] P. Charneau,et al. The Maturation of Dendritic Cells Results in Postintegration Inhibition of HIV-1 Replication1 , 2001, The Journal of Immunology.
[39] M. Emerman,et al. Vpx association with mature core structures of HIV-2. , 1996, Virology.
[40] X. Yu,et al. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage , 1991, Journal of virology.
[41] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[42] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.